Susquehanna International Group
EIGR

Susquehanna International Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Susquehanna International Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-850
Closed -$5.73K – 13706
2023
Q4 		$5.73K Buy
850
+127
+18% +$1.12K ﹤0.01% 12119
2023
Q3 		$6.62K Sell
723
-658
-48% -$13.2K ﹤0.01% 11755
2023
Q2 		$29.2K Buy
1,381
+736
+114% +$22.7K ﹤0.01% 11525
2023
Q1 		$17.4K Buy
645
+300
+87% +$14K ﹤0.01% 12080
2022
Q4 		$12.2K Sell
345
-67
-16% -$8.05K ﹤0.01% 11902
2022
Q3 		$93K Sell
412
-217
-34% -$53.3K ﹤0.01% 11764
2022
Q2 		$119K Buy
+629
New +$127K ﹤0.01% 11292
2022
Q1 		– Sell
-1,597
Closed -$252K – 14236
2021
Q4 		$249K Buy
1,597
+4
+0.3% +$774 ﹤0.01% 10955
2021
Q3 		$319K Buy
1,593
+291
+22% +$69.2K ﹤0.01% 10467
2021
Q2 		$333K Buy
+1,302
New +$325K ﹤0.01% 10541
2020
Q4 		– Sell
-2,592
Closed -$743K – 11886
2020
Q3 		$633K Buy
+2,592
New +$806K ﹤0.01% 7178
2020
Q2 		– Sell
-588
Closed -$120K – 11147
2020
Q1 		$120K Buy
+588
New +$187K ﹤0.01% 9196
2019
Q4 		– Sell
-471
Closed -$167K – 10863
2019
Q3 		$145K Sell
471
-835
-64% -$271K ﹤0.01% 9346
2019
Q2 		$415K Sell
1,306
-1,725
-57% -$597K ﹤0.01% 7659
2019
Q1 		$1.27M Buy
3,031
+1,466
+94% +$588K ﹤0.01% 4550
2018
Q4 		$477K Buy
+1,565
New +$506K ﹤0.01% 6126
2017
Q3 		– Sell
-480
Closed -$114K – 9808
2017
Q2 		$114K Buy
+480
New +$109K ﹤0.01% 8629
2016
Q1 		– Sell
-41
Closed -$27K – 9823
2015
Q4 		$27K Sell
41
-35
-46% -$19.8K ﹤0.01% 9188
2015
Q3 		$36K Sell
76
-360
-83% -$191K ﹤0.01% 9424
2015
Q2 		$248K Buy
436
+325
+293% +$899K ﹤0.01% 8898
2015
Q1 		$947K Buy
111
+88
+383% +$769K ﹤0.01% 5871
2014
Q4 		$199K Buy
+23
New +$133K ﹤0.01% 8831

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $356M AUM 14.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Susquehanna International Group's EIGR Position: Q1 2024 in Review

Susquehanna International Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 850 shares — an estimated $5.73K sold.

Susquehanna International Group first reported a position in EIGR in Q4 2014 and held it in 22 quarters. The position peaked at $1.27M in Q1 2019. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Susquehanna International Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 850 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $5.73K.
  • Susquehanna International Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2014 and held it in 22 quarters.
  • Susquehanna International Group's Eiger BioPharmaceuticals, Inc. position peaked at $1.27M in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.